We are live on
!
Find out more
Summit Partners Public Asset Management Portfolio holdings
AUM
$5.69B
Turnover
70.51%
1-Year Est. Return
259.25%
This Fund
S&P 500
This Quarter
Est. Return
+26.46%
1 Year Est. Return
+259.25%
3 Year Est. Return
+1,166.96%
5 Year Est. Return
+1,972.9%
10 Year Est. Return
+39,131.96%
AUM
$4.81B
AUM Growth
-$10.4M
(-0.22%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
27.78%
Holding
221
New
56
Increased
28
Reduced
33
Closed
97
Avg Time Held Equity + Options
0.5
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$66.4M |
| 2 |
Natera
NTRA
|
+$59.3M |
| 3 |
Cidara Therapeutics
CDTX
|
+$56.2M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$53.7M |
| 5 |
Credo Technology Group
CRDO
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$191M |
| 2 |
Commault Systems
CVLT
|
+$74.9M |
| 3 |
Mercado Libre
MELI
|
+$42.5M |
| 4 |
TSMC
TSM
|
+$37.8M |
| 5 |
Waystar Holding Corp
WAY
|
+$33.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Miscellaneous | 26.08% |
| 3 | Healthcare | 21.85% |
| 4 | Industrials | 8.52% |
| 5 | Communication Services | 5.11% |
Similar funds
Summit Partners Public Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Summit Partners Public Asset Management held 221 positions worth $4.81B, down 0.22% from $4.82B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Summit Partners Public Asset Management's Q4 2025 filing shows 56 new, 28 increased, 33 reduced and 97 closed positions. Its largest new stake was SiTime: 123,958 shares worth $43.8M. The largest sale was Verona Pharma, an estimated $191M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- Summit Partners Public Asset Management's largest Q4 2025 buy was SiTime: 123,958 shares worth $43.8M.
- Summit Partners Public Asset Management added most to Guardant Health in Q4 2025, an estimated $66.4M increase.
- Summit Partners Public Asset Management's biggest Q4 2025 reduction was TSMC, cutting an estimated $37.8M.
- Summit Partners Public Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $191M.
- Summit Partners Public Asset Management's ten largest holdings make up 28% of its $4.81B portfolio in Q4 2025.
- Summit Partners Public Asset Management opened 56 new positions and closed 97 in Q4 2025.
- Summit Partners Public Asset Management's portfolio value fell 0.22% quarter-over-quarter to $4.81B.
Based on Summit Partners Public Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.